Kathleen M Fox

Summary

Country: USA

Publications

  1. ncbi Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, Monkton, Maryland 21111, USA
    Clin Ther 28:388-95. 2006
  2. ncbi Perceived body image in men and women with type 2 diabetes mellitus: correlation of body mass index with the figure rating scale
    Harold E Bays
    Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA
    Nutr J 8:57. 2009
  3. ncbi Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes)
    Harold E Bays
    Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA
    BMC Public Health 7:277. 2007
  4. ncbi Atherosclerosis profile and incidence of cardiovascular events: a population-based survey
    Jennifer G Robinson
    Department of Medicine, University of Iowa, Iowa City, IA, USA
    BMC Cardiovasc Disord 9:46. 2009
  5. ncbi Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database
    Kathleen M Fox
    Department of Epidemiology and Preventive Medicine, School of Medicine, University of Maryland, Baltimore, MD, USA
    Clin Ther 29:2385-94. 2007
  6. ncbi Metastatic non-small cell lung cancer: costs associated with disease progression
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, PO Box 543, Monkton, MD 21111, USA
    Am J Manag Care 14:565-71. 2008
  7. ncbi Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data
    K M Fox
    Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
    Int J Clin Pract 61:1634-42. 2007
  8. ncbi Out-of-pocket expenses and healthcare resource utilization among individuals with or at risk of diabetes mellitus
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, Monkton, MD 21111, USA
    Curr Med Res Opin 24:3323-9. 2008
  9. ncbi Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective
    Kathleen M Fox
    University of Maryland School of Medicine, Department of Epidemiology and Preventive Medicine, Baltimore, MD, USA
    Curr Med Res Opin 23:2125-33. 2007
  10. ncbi Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting
    Kathleen M Fox
    Am J Manag Care 13:S270-5. 2007

Collaborators

Detail Information

Publications23

  1. ncbi Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, Monkton, Maryland 21111, USA
    Clin Ther 28:388-95. 2006
    ..Since the mid-1990s, the development of new oral antidiabetic agents (OAs) and treatment guidelines have created an opportunity to improve glycemic control in patients with type 2 diabetes...
  2. ncbi Perceived body image in men and women with type 2 diabetes mellitus: correlation of body mass index with the figure rating scale
    Harold E Bays
    Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA
    Nutr J 8:57. 2009
    ..This study examined the self-perception of body image to various levels of BMI among those with T2DM...
  3. ncbi Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes)
    Harold E Bays
    Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA
    BMC Public Health 7:277. 2007
    ....
  4. ncbi Atherosclerosis profile and incidence of cardiovascular events: a population-based survey
    Jennifer G Robinson
    Department of Medicine, University of Iowa, Iowa City, IA, USA
    BMC Cardiovasc Disord 9:46. 2009
    ..This study evaluated the characteristics of individuals with a diagnosis of atherosclerosis and estimated the incidence of CVD events to assist in the early identification of high-risk individuals...
  5. ncbi Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database
    Kathleen M Fox
    Department of Epidemiology and Preventive Medicine, School of Medicine, University of Maryland, Baltimore, MD, USA
    Clin Ther 29:2385-94. 2007
    ..Lipid management in clinical practice has been suboptimal with a significant proportion of patients not achieving recommended cholesterol levels. A reason for low goal attainment may be the limited use of upward dose titration...
  6. ncbi Metastatic non-small cell lung cancer: costs associated with disease progression
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, PO Box 543, Monkton, MD 21111, USA
    Am J Manag Care 14:565-71. 2008
    ..To compare direct costs of care among patients having advanced non-small cell lung cancer (NSCLC) with versus without disease progression following first-line chemotherapy...
  7. ncbi Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data
    K M Fox
    Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
    Int J Clin Pract 61:1634-42. 2007
    ....
  8. ncbi Out-of-pocket expenses and healthcare resource utilization among individuals with or at risk of diabetes mellitus
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, Monkton, MD 21111, USA
    Curr Med Res Opin 24:3323-9. 2008
    ..Self-reported healthcare resource utilization (HRU), medication out-of-pocket (OOP) expenditures and impact of OOP expenses on HRU were assessed for respondents with type 2 diabetes mellitus (T2DM) or elevated cardiometabolic risk...
  9. ncbi Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective
    Kathleen M Fox
    University of Maryland School of Medicine, Department of Epidemiology and Preventive Medicine, Baltimore, MD, USA
    Curr Med Res Opin 23:2125-33. 2007
    ..To compare effectiveness of rosuvastatin (RSV) with other statins on lowering low-density lipoprotein cholesterol (LDL-C) and LDL-C goal attainment among patients with type 1 or type 2 diabetes mellitus...
  10. ncbi Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting
    Kathleen M Fox
    Am J Manag Care 13:S270-5. 2007
    ..The study compared low-density lipoprotein cholesterol (LDL-C) reduction obtained after switching patients on a statin therapy to rosuvastatin or simvastatin in real-world clinical practice...
  11. ncbi Impact of obesity on work productivity and role disability in individuals with and at risk for diabetes mellitus
    Helena W Rodbard
    Endocrine and Metabolic Consultants, LLC, Rockville, Maryland, USA
    Am J Health Promot 23:353-60. 2009
    ..Evaluate work absence, work productivity, and disruption of work, social, and family life among individuals of varying body mass index (BMI) with or at risk for diabetes mellitus...
  12. ncbi Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses
    Helena W Rodbard
    Endocrine and Metabolic Associates, Rockville, MD, USA
    Diabetes Res Clin Pract 87:360-5. 2010
    ..The number of prescription medications and out-of-pocket expenses of individuals with type 2 diabetes mellitus (T2DM) were evaluated to assess the economic burden of diabetes...
  13. ncbi Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, Monkton, MD 21111, USA
    BMC Nephrol 13:5. 2012
    ..This study describes the proportion of patients transfused, units of blood transfused and trigger-hemoglobin (Hb) levels for transfusions in severe anemic, ND-CKD patients in routine practice...
  14. ncbi Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study
    Stephen Seliger
    Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Clin J Am Soc Nephrol 5:882-8. 2010
    ..Risk of mortality, hospitalizations, and blood transfusion were compared among nondialysis CKD patients with "early" versus "delayed" ESA initiation...
  15. ncbi EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD)
    Susan Grandy
    Strategic Healthcare Solutions, LLC, Monkton, MD, USA
    Health Qual Life Outcomes 6:18. 2008
    ..The EQ-5D was used to compare burden experienced by respondents with diabetes and those at risk for diabetes...
  16. ncbi Race/Ethnicity and gender differences in health intentions and behaviors regarding exercise and diet for adults with type 2 diabetes: a cross-sectional analysis
    James R Gavin
    Strategic Healthcare Solutions, LLC, Monkton, MD 21111, USA
    BMC Public Health 11:533. 2011
    ..This study evaluated the differences across racial-ethnic groups in self-reported medical advice received and health intentions and behaviors among adults with type 2 diabetes mellitus...
  17. ncbi Estimation of Cachexia among Cancer Patients Based on Four Definitions
    Kathleen M Fox
    Strategic Healthcare Solutions, LLC, P O Box 543, Monkton, MD 21111, USA
    J Oncol 2009:693458. 2009
    ..7% with >/=5% weight loss. Conclusions. The proportion of patients with cachexia varied considerably depending upon the definition employed, indicating that a standard operational definition is needed...
  18. ncbi Predictors of bone loss after hip fracture
    Lois E Wehren
    Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 660 West Redwood Street, MD 21201, Baltimore, USA
    Osteoporos Int 15:125-31. 2004
    ....
  19. ncbi Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice
    Robert L Ohsfeldt
    Texas A and M Health Science Center, Department of Health Policy and Management, College Station, TX 77840, USA
    Am J Manag Care 12:S412-23. 2006
    ..The objective of the present study was to estimate the clinical effectiveness and cost-effectiveness of rosuvastatin compared with atorvastatin or simvastatin among high-risk patients as treated in routine clinical practice...
  20. ncbi Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists
    Vaishali Patel
    Amgen Inc, Thousand Oaks, California, USA
    J Am Acad Dermatol 58:964-9. 2008
    ..The study evaluated community physician prescribing patterns for patients with psoriasis...
  21. ncbi Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD)
    Nathaniel G Clark
    American Diabetes Association, Alexandria, Virginia, USA
    Diabetes Care 30:2868-73. 2007
    ..The Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) examined prevalence of ADA symptoms and their association with diabetes diagnosis...
  22. ncbi Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey
    Elizabeth J Horn
    National Psoriasis Foundation, Portland, Oregon 97223 7195, USA
    J Am Acad Dermatol 57:957-62. 2007
    ..We sought to assess whether patients with psoriasis with moderate or severe disease are being treated with systemic therapy...
  23. ncbi Comparison of self-reported survey (SHIELD) versus NHANES data in estimating prevalence of dyslipidemia
    Harold E Bays
    Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA
    Curr Med Res Opin 24:1179-86. 2008
    ....